Creative Biolabs delivers end-to-end CRO support for Oxalobacter formigenes programs—built for microbiome innovators, live biotherapeutic developers, and next-generation probiotic teams. From strain recovery to decision-grade functional, molecular, and safety datasets, each study is designed to reduce technical uncertainty and accelerate confident R&D choices under strict anaerobic constraints.
Reliable, strain-level O. formigenes data packages that remain defensible across studies, sites, and batches.
O. formigenes is a strict anaerobe that uses oxalate as a core energy substrate, making routine handling and quantification non-trivial. The biology is compelling precisely because it is specialized: oxalate utilization is linked to key enzymes such as formyl-CoA transferase (FRC) and oxalyl-CoA decarboxylase (OXC), and multiple studies connect colonization status with meaningful differences in stone-former risk profiles.
Clinical-adjacent research has also progressed beyond “presence/absence.” Trials and protocols have evaluated orally administered O. formigenes (e.g., Oxabact/Oxalobacter-based products) in primary hyperoxaluria research settings, highlighting the need for standardized potency, stability, and comparability frameworks that match real manufacturing and translational expectations.
O. formigenes can be difficult to recover from complex fecal matrices, especially after antibiotic exposure and oxygen stress. Creative Biolabs applies oxalate-enriched selective media, strict anaerobic workflows, and targeted enrichment to isolate wild-type O. formigenes candidates, then screens for high oxalate-degradation performance to establish an activity-ranked strain bank.
Functional confirmation starts with direct oxalate degradation assays and expands into mechanism-oriented readouts. For O. formigenes, Creative Biolabs quantifies pathway-relevant markers—including OXC and FRC expression/activity—then links functional kinetics to study-appropriate endpoints, supporting MoA narratives consistent with oxalate turnover and intestinal oxalate handling research.
Because O. formigenes is not reliably captured by routine culture-based enumeration, sensitive molecular quantification is often essential. Creative Biolabs designs and validates high-specificity primers/probes targeting O. formigenes genes (commonly oxc), enabling robust qPCR/ddPCR-style detection in mixed samples, longitudinal studies, and analytically demanding matrices.
O. formigenes grows slowly and requires stringent anaerobiosis, which can suppress biomass and complicate scale translation. Creative Biolabs develops fermentation parameter sets for O. formigenes (pH control, oxalate feeding strategy, redox management), aiming for higher-density runs while preserving phenotype fidelity and downstream compatibility with formulation and release testing.
Formulation must protect O. formigenes against oxygen exposure and gastric transit stress while maintaining viability and functional integrity. Creative Biolabs evaluates encapsulation and barrier strategies (e.g., microencapsulation, protective matrices, enteric-aligned approaches) to improve survivability profiles and support consistent delivery to the lower GI environment for research performance.
Potency for O. formigenes should not rely on CFU alone, especially when metabolic function is the value driver. Creative Biolabs builds potency frameworks that combine viable count where appropriate with functional oxalate-degradation rates, creating batch-to-batch potency definitions aligned with mechanism-relevant activity rather than enumeration alone.
O. formigenes is highly oxygen-sensitive, so stability must be evaluated under realistic packaging and distribution conditions. Creative Biolabs conducts accelerated and long-term stability studies across temperature/humidity and oxygen-barrier variables, tracking viability and functional retention to support shelf-life rationales and development-stage comparability plans.
Safety profiling for O. formigenes programs typically includes antibiotic susceptibility patterns, hemolysis testing, and targeted screens for virulence-associated features. Creative Biolabs aligns study design with common LBP/probiotic safety expectations to generate clear, review-ready safety packages suitable for research progression decisions.
Translate your O. formigenes hypothesis into measurable, decision-ready study endpoints.
Secure transport, oxygen control, and standardized handling for O. formigenes materials.
Enrich, isolate, and verify O. formigenes identity and baseline phenotype.
Quantify O. formigenes oxalate turnover plus pathway-relevant markers and genes.
Optimize O. formigenes growth and delivery formats matched to study needs.
Deliver integrated O. formigenes release-style datasets for confident next steps.
Designed to protect strict anaerobes like O. formigenes from oxygen-driven variability.
Potency and identity data engineered for comparability, not one-off experiments.
Functional assays anchored to O. formigenes oxalate metabolism biology.
Methods chosen to remain interpretable across cohorts, matrices, and timepoints.
Fermentation and formulation strategies built with downstream constraints in mind.
Traceable protocols and reporting for audit-friendly, reproducible O. formigenes programs.
A primary research direction evaluates whether gut colonization by O. formigenes can reduce dietary oxalate absorption and shift urinary oxalate dynamics—key variables associated with calcium oxalate stone risk. Case-control evidence links O. formigenes colonization with lower recurrent stone-former odds.
O. formigenes has been studied in primary hyperoxaluria research programs, including controlled trial designs and long-term evaluations of orally administered preparations (e.g., Oxabact/Oxalobacter-based candidates). These efforts highlight the importance of standardized potency, stability, and safety datasets.
Because antibiotic exposure can disrupt colonization, O. formigenes is frequently discussed in the context of microbiome restoration and next-generation probiotic concepts aimed at rebuilding oxalate-degrading capacity after microbiota perturbation—an area where strain selection and viability preservation are decisive.
Fecal detection of O. formigenes—often via gene-targeted molecular assays—has been used in research settings to stratify recurrence risk and study cohorts. The challenge is analytical sensitivity and specificity in complex samples, making validated oxc-aligned assays especially valuable.
Originally identified in animal hosts, O. formigenes continues to appear in animal health research exploring oxalate load handling in livestock exposed to oxalate-rich feed or forage. These studies often emphasize safety profiling and performance under field-relevant storage constraints.
Beyond live-cell approaches, recent work has identified O. formigenes–derived factors (including peptides P8 and P9) that stimulate epithelial oxalate transport in human cell and organoid models—supporting discovery programs focused on secreted-factor mechanisms and downstream non-living modality concepts.
Representative O. formigenes strains are available to support strain-specific research.
| Product Name | Catalog No. | Target | Product Overview | Size | Price |
|---|---|---|---|---|---|
| Oxalobacter formigenes; 4420 | LBSX-0522-GF65 | Oxalobacter | Oxalobacter formigenes is a Gram-negative, oxalate-degrading anaerobic bacterium isolated from human faeces. | — | Inquiry |
| Oxalobacter formigenes | LBSX-0522-GF66 | Oxalobacter | Oxalobacter formigenes is a Gram-negative, oxalate-degrading anaerobic bacterium isolated from sheep rumen. | — | Inquiry |
| Oxalobacter formigenes; 105951 | LBSX-0522-GF67 | Oxalobacter | Oxalobacter formigenes is a Gram-negative, oxalate-degrading anaerobic bacterium. | — | Inquiry |
Identity confirmation typically combines anaerobic culture characteristics with gene-based verification (e.g., oxc and other targets) and sequencing as needed. This reduces false positives from phenotypically similar anaerobes present in stool-derived communities.
For O. formigenes, functional oxalate-degradation rate is often more meaningful than CFU alone. A combined approach—viability plus function—better reflects mechanism-relevant performance and supports batch comparability across development stages.
Common matrices include fecal samples, cultured biomass, formulation intermediates, and complex study samples. Because inhibitors vary by matrix, validated extraction and assay controls are essential to maintain reliable O. formigenes quantitative readouts.
Oxygen control is handled through anaerobic workflow design, oxygen-scavenging packaging strategies, and time-bounded exposure limits. Stability and functional checkpoints are integrated so O. formigenes performance reflects biology—not handling artifacts.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.